nejm.org
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide,
a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like
peptide-1 receptor...